The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
England’s heartbreaking World Cup exit attracted a massive television audience, making it the most-watched live TV moment of 2026 so far. Around 24 million viewers tuned in to watch Argentina’s late 2-1
MoreAdvanced therapy supply chains are undergoing a fundamental transformation as regulatory expectations and patient-centric risk considerations continue to intensify across the industry. Adam Fox, Chief Quality and Regulatory Affairs Officer of Cryoport
MoreNew York has made history by becoming the first US state to enact a statewide moratorium on certain artificial intelligence data centre development projects. The move marks a significant departure from the
MoreThe Theodore Roosevelt Presidential Library opened its doors to the public for the first time last week, drawing visitors from across the country to North Dakota. Despite President Donald Trump making an
MoreBloom Energy Corporation (NYSE: BE) has attracted renewed investor attention as markets speculate on the Federal Reserve’s next moves regarding interest rate policy. The company, which specialises in clean energy fuel cell
MoreLondon’s most prestigious law firms are facing significant financial and strategic obstacles as they attempt to establish themselves in the highly competitive New York legal market. Breaking into the US has been
MoreCryoport Systems is repositioning the conversation around supply chains for advanced therapies, arguing that quality must be embedded from the ground up rather than applied as an afterthought. Adam Fox, Chief Quality
MoreThe law firms that struck agreements with the Trump administration are finding those arrangements have generated far more problems than they solved. Reports suggest the deals negotiated between several prominent Biglaw firms
MoreThe FIFA World Cup delivered a welcome lift to bars and restaurants in host cities, though the wider economic impact fell short of expectations, the Federal Reserve has found. The Federal Reserve’s
MoreMerck (MRK) has announced that its flagship cancer drug Keytruda has achieved a landmark result in the treatment of a specific endometrial cancer subtype. The drug became the first PD-1 inhibitor to
More
